The Lowenthal-Muller Grant for Translational Research

The RHH Research Foundation is proud to offer the new Lowenthal-Muller Grant for Translational Research in 2023. This single, one-off grant, marking the Foundation’s 25th year, acknowledges the service of founding Board members Professor Ray Lowenthal and Professor Konrad Muller, who both made such a valuable contribution to the RHH Research Foundation in its early years.

The Lowenthal-Muller Grant will be available for an amount of up to $200,000 (ex gst) over two years, to be allocated on the basis of $100k per annum (+/- 20% each year), and is focused on supporting translational research.

Aim of the Lowenthal-Muller Grant:

The aim of this grant is to support a researcher or research team to undertake high quality health care translational research in one of the Foundation’s five strategic priority areas. Translation is a critical phase connecting health research to patient outcomes. As the NHMRC states:

‘the creation of knowledge does not, of itself, lead to widespread implementation and positive impacts on health. The knowledge must be translated into changes in practice and policy for the benefits and impacts to flow …’.

The Lowenthal-Muller Grant targets translational research that supports the implementation of research findings to improve health outcomes for Tasmanians and their communities.

Applications are open to all suitably qualified scientific and medical researchers at any career stage.

Download the Lowenthal-Muller Grant Guidelines.

Apply

Applications have closed.

Assessment timetable:

Applications will be assessed during September/October 2022. These are reviewed by the Foundation's Scientific Research Advisory Committee (SRAC) and the Foundation’s Board.

Applicants will be notified of outcomes by early November 2022.

For enquiries please contact: research@rhhresearchfoundation.org or (03) 6166 1320.